Clinical Trials
99 trialsAnalysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
Fox Chase Cancer Center
Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging
Oslo University Hospital
Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
Lanzhou University Second Hospital
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
University Health Network, Toronto
DRIVE
Pacific Edge Limited
microDRIVE
Pacific Edge Limited
Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer
Assiut University
AVENANCE
Pfizer
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Tel-Aviv Sourasky Medical Center
MicroBlad
University Hospital, Toulouse
Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Korean Prospective Upper Tract Urothelial Carcinoma Cohort
Samsung Medical Center
Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
Tianjin Medical University Second Hospital
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
P-EVOLUTION
Comprehensive Cancer Center Munich (CCCM)
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
Dana-Farber Cancer Institute
SOGUG-PRINCIS
Spanish Oncology Genito-Urinary Group
WASHOUT
British Urology Researchers in Surgical Training
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center
A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer
Pfizer
FLORAL
University Hospital, Strasbourg, France
OUAF
University Hospital, Strasbourg, France
IMreal
Hoffmann-La Roche
Evaluating Bladder CAREâ„¢, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases
Pangea Laboratory LLC
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
Peking University First Hospital
Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study
Mayo Clinic
A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing
British Columbia Cancer Agency
AMI
Centre Hospitalier Universitaire de Nīmes
BLUSH
Vastra Gotaland Region
INSITE
Fox Chase Cancer Center
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
UROSCOUT-1
Tampere University Hospital
CARAT
iOMEDICO AG
ST-ICI02
University of Erlangen-Nürnberg Medical School
SPARC
King's College London
HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
Seagen Inc.
Neurological Function in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin-Based Therapy
National Taiwan University Hospital
URADJ
Bristol-Myers Squibb
Urolife
IRCCS San Raffaele
Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER
AstraZeneca
UMT-UC
Shanghai Epiprobe Biotechnology Co., Ltd.
ARON-2 Study-Multicentric International Retrospective Study
Hospital of Macerata
A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
A Multicenter Cancer Biospecimen Collection Study
Cofactor Genomics, Inc.
uTRACT
UroGen Pharma Ltd.
A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China
Creative Biosciences (Guangzhou) Co., Ltd.
Current Status of Diagnosis and Treatment of Uroepithelial Carcinoma
The First Affiliated Hospital of Xinxiang Medical College
The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma
Wuhan Ammunition Life-tech Co., Ltd
Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria
Changhai Hospital
Urine DNA Methylation Detection for Hematuria Evaluation
Changhai Hospital